Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines

OBJECTIVES: The identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen or RNA in respiratory specimens ≥14 days after administration of all recommended doses of authorized coronavirus disease 2019 (COVID-19) vaccines is defined as breakthrough infection. In the presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunner-Ziegler, Sophie, Spath, Tibor, Kornek, Gabriela, König, Franz, Parschalk, Bernhard, Schnetzinger, Maximilian, Straßl, Robert Paul, Savic, Rebeka, Foit, Andrea, Resch, Helene, Thalhammer, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667425/
https://www.ncbi.nlm.nih.gov/pubmed/34915073
http://dx.doi.org/10.1016/j.cmi.2021.11.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667425/
https://www.ncbi.nlm.nih.gov/pubmed/34915073
http://dx.doi.org/10.1016/j.cmi.2021.11.023

Ejemplares similares